🔗 Visit the ClinicalTrials.gov page for NCT02365831
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. | Lancet | 2007 | 9.24 |
| 2 | Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer. | J Clin Oncol | 2011 | 3.02 |
| 3 | Adjuvant systemic treatment of early breast cancer: the NORA study. | Ann Oncol | 2006 | 0.89 |